Literature DB >> 15294966

Up-regulation of vascular endothelial growth factor (VEGF) in small-for-size liver grafts enhances macrophage activities through VEGF receptor 2-dependent pathway.

Zhen Fan Yang1, Ronnie T Poon, Ying Luo, Cindy K Cheung, David W Ho, Chung Mau Lo, Sheung Tat Fan.   

Abstract

This study aims to investigate the potential role of vascular endothelial growth factor (VEGF) and VEGF-R2 (fetal liver kinase (Flk)-1) in mediating macrophage activities in small-for-size liver transplantation. A rat orthotopic liver transplantation model was performed using either whole, 50, or 30% liver grafts (both 50 and 30% were regarded as small-for-size) in syngeneic or allogeneic combinations, respectively. Firstly, the mRNA and protein levels of VEGF and Flk-1 in liver grafts were detected by RT-PCR and Western blot, and the number of Flk-1(+) macrophages (labeled by ED1) was determined by flow cytometry. It was found that the small-for-size isografts and allografts presented higher levels of VEGF and Flk-1 expression than the whole isograft and allograft. In addition, a higher number of Flk-1(+)ED1(+) cells were detected in the small-for-size isografts and allografts than the whole isograft and allograft. Secondly, our study revealed that macrophage cell lines did not initially express detectable Flk-1, but could be induced by VEGF, and the inducible expression of Flk-1 in macrophages was related to their migration and proliferation activities. Finally, our study demonstrated that the induction of Flk-1 expression on macrophages by VEGF was associated with the expression of NF-kappaB and heat shock protein 90. In conclusion, the present study showed that the up-regulated expression of VEGF and its interaction with Flk-1 in small-for-size liver grafts might facilitate the activities of macrophages.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15294966     DOI: 10.4049/jimmunol.173.4.2507

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

Review 1.  Small-for-size syndrome in living-donor liver transplantation using a left lobe graft.

Authors:  Masahiko Taniguchi; Tsuyoshi Shimamura; Satoru Todo; Hiroyuki Furukawa
Journal:  Surg Today       Date:  2014-06-05       Impact factor: 2.549

Review 2.  Liver transplantation for hepatocellular carcinoma from living-donor vs. deceased donor.

Authors:  Nobuhisa Akamatsu; Norihiro Kokudo
Journal:  Hepatobiliary Surg Nutr       Date:  2016-10       Impact factor: 7.293

3.  Distinct roles of VEGFR-1 and VEGFR-2 in the aberrant hematopoiesis associated with elevated levels of VEGF.

Authors:  Yuhui Huang; Xiaolan Chen; Mikhail M Dikov; Sergey V Novitskiy; Claudio A Mosse; Li Yang; David P Carbone
Journal:  Blood       Date:  2007-03-21       Impact factor: 22.113

4.  VEGF receptor 1 signaling is essential for osteoclast development and bone marrow formation in colony-stimulating factor 1-deficient mice.

Authors:  Shumpei Niida; Takako Kondo; Sachie Hiratsuka; Shin-Ichi Hayashi; Norio Amizuka; Tetsuo Noda; Kyoji Ikeda; Masabumi Shibuya
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-19       Impact factor: 11.205

5.  Monocytic/macrophagic pneumonitis after intrabronchial deposition of vascular endothelial growth factor in neonatal lambs.

Authors:  D K Meyerholz; B Grubor; T Lazic; J M Gallup; M M A de Macedo; P B McCray; M R Ackermann
Journal:  Vet Pathol       Date:  2006-09       Impact factor: 2.221

6.  Lymphangiogenesis-independent resolution of experimental edema.

Authors:  Emily L Ongstad; Echoe M Bouta; Jaclynn E Roberts; Joseph S Uzarski; Sara E Gibbs; Michael S Sabel; Vincent M Cimmino; Melissa A Roberts; Jeremy Goldman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-03-05       Impact factor: 4.733

Review 7.  Intrahepatic recurrence of hepatocellular carcinoma after resection: an update.

Authors:  Maria Tampaki; George Vasileios Papatheodoridis; Evangelos Cholongitas
Journal:  Clin J Gastroenterol       Date:  2021-03-27

Review 8.  Living donor liver transplantation for hepatocellular cancer: an (almost) exclusive Eastern procedure?

Authors:  Rafael S Pinheiro; Daniel R Waisberg; Lucas S Nacif; Vinicius Rocha-Santos; Rubens M Arantes; Liliana Ducatti; Rodrigo B Martino; Quirino Lai; Wellington Andraus; Luiz A C D'Albuquerque
Journal:  Transl Gastroenterol Hepatol       Date:  2017-08-29

Review 9.  Impact of non-oncological factors on tumor recurrence after liver transplantation in hepatocellular carcinoma patients.

Authors:  Xiang-Qian Gu; Wei-Ping Zheng; Da-Hong Teng; Ji-San Sun; Hong Zheng
Journal:  World J Gastroenterol       Date:  2016-03-07       Impact factor: 5.742

10.  Anti-VEGFR therapy is one of the healing inhibitors of antiresorptive-related osteonecrosis of the jaw.

Authors:  Chihiro Kanno; Tetsuharu Kaneko; Manabu Endo; Takehiro Kitabatake; Tomoko Sakuma; Yoshiaki Kanaya; Yuki Watanabe; Hiroshi Hasegawa
Journal:  J Bone Miner Metab       Date:  2020-11-16       Impact factor: 2.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.